Puma Biotechnology logo
Puma Biotechnology PBYI
$ 6.97 1.16%

Annual report 2025
added 02-26-2026

report update icon

Puma Biotechnology Long Term Debt Current 2011-2026 | PBYI

Annual Long Term Debt Current Puma Biotechnology

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.31 M 5.54 M 4.8 M 4.14 M 3.57 M 3.09 M 2.62 M - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
5.54 M 1.31 M 3.58 M

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Amgen Amgen
AMGN
135 M $ 340.0 -0.75 % $ 183 B usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
6.76 M $ 12.32 -0.24 % $ 3.86 B usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 23.27 -1.63 % $ 2.96 B usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.36 -2.16 % $ 362 M britainBritain
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.76 4.35 % $ 9.05 B australiaAustralia
CymaBay Therapeutics CymaBay Therapeutics
CBAY
7 K - - $ 3.45 B usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.57 -3.38 % $ 16.1 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
1.35 M - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
1.38 M - - $ 1.41 B usaUSA
Cellectar Biosciences Cellectar Biosciences
CLRB
100 K $ 2.75 1.48 % $ 7.17 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
1.16 M - - $ 401 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
781 K - - $ 1.2 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
Cyclerion Therapeutics Cyclerion Therapeutics
CYCN
3.29 M $ 3.48 -16.14 % $ 8.76 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
3.5 M - - $ 2.18 B usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
4.18 M - - $ 2.02 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Dyadic International Dyadic International
DYAI
34.6 K $ 0.88 1.66 % $ 31.8 M usaUSA
BioNTech SE BioNTech SE
BNTX
45 M $ 89.62 -1.82 % $ 27.2 B germanyGermany
Coherus BioSciences Coherus BioSciences
CHRS
1.83 M $ 1.67 - $ 196 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA